Shycocan, a breakthrough virus-attenuation device invented and manufactured in India, was established in the UAE in the global Seminar of Pharmacy and Medicine (ICPM) held in Sharjah. This marks the Middle East introduction of the item, the very first of its type in the entire world, that’s seeing a strong demand from institutional buyers around the world at times of their raging Coronavirus pandemic.
The cylindrical apparatus, Shycocan, is clinically determined to neutralise and help curb the spread of the Coronavirus and Influenza household of germs in indoor spaces using 99.9% efficiency, allowing schools, schools, houses and companies like hospitals, hotels, offices, restaurants, auditoriums, transport, airports and retail return to normal and serve the consumers in a secure atmosphere.
Remarkably, Shycocan also functions on all present and potential versions and mutants of those viruses, protecting people’s health and saving countless hours of lost productivity.
Alok Sharma, Chief Executive Officer, Shycocan Corporation, stated, “The planet confronted one of its most significant challenges with the outbreak, bringing us into a standstill. More livelihoods than lives are lost, in actuality, close to a thousand in the last count. Science, innovation and technology will play a major part in helping us recover our lives and operate safely. We’re thrilled to start the pathbreaking one-of-a-kind virus-attenuation device, the Shycocan, at the UAE from the expectation of assisting individuals bring lives and businesses back to normal. And we could not have discovered a much more credible and appropriate platform compared to the esteemed ICPM to flaunt our cutting-edge technologies .”
Shycocan is dispersed from the UAE for customers and business clients by Redington Middle East LLC and Ibn Batuta Medicine & Medical Equipment Store LLC. It’s among the most thoroughly analyzed apparatus for both efficacy and safety. It uses nor emits radiation, chemicals, ozone or some other poisonous substance. It’s 100% safe for people, animals and the environment. In addition, it doesn’t damage the bronchial ecosystem and microbes that flourish in the environment and are vital for our immunity.
Said the scientist Dr. Rajah Vijay Kumar, the inventor of Shycocan,”Coronavirus-type outbreaks are happening with quicker intermittent frequencies. The COVID-19 breed is becoming more contagious and deadlier with consecutive mutations from the previous 17 years, underscoring the significance of a device like Shycocan. The largest challenge of the virus is the infectivity or virulence.
Breaking the series of infectivity demands focused work on indoor surroundings since they take the maximum risk of transmission. In 2017, our campus at Bengaluru experienced many episodes of seasonal influenza, forcing me to design, construct and set up the system that was later christened Shycocan. A year after, the prevalence of seasonal influenza was almost completely absent in the campus. After the COVID-19 pandemic struck, the apparatus was shipped for testing and regulatory compliances to international labs and found to be both effective against it. It was overwhelming to realise that we’d already created the world’s first technology to fight the pandemic long before picturing the possibility of such a catastrophe taking the whole world in its grasp.”
Shycocan has widespread use across market segments, such as hospitals, clinics, schools, higher education associations, banking industry, retail and manufacturing outlets, hospitality industry, government offices, property businesses and companies. Additionally, the business provides customised consultations, a one-time replacement guarantee, powerful service and support network across the UAE, along with a post-installation audit.
A single device when mounted includes an effective coverage area of 1,000 square feet (10,000 cubic feet). A number of devices may be installed to pay a bigger indoor area. The apparatus has seen a strong demand from institutional buyers throughout the planet and is currently being used in countries including India, the United States, Europe, Malaysia, Australia, New Zealand and South Africa, amongst others.
Dr Abdullah Al Kindi, Chairman & CEO, ICPM, stated,”Mankind is facing one of the most difficult times – something which has affected lives, livelihoods and companies in a worldwide scale. We as international citizens want the very best of science, engineering, social obligation, and willpower to combat it and succeed. ICPM was created with responsibility towards humankind and with health care as its base. It gives me enormous pleasure to start Shycocan on this stage. It’s a product with advanced technology and the capacity to attract lives and businesses back to normal.”